Ind-Swift Labs. (INDSWFTLAB)
FAST GROWERFairStock Score: 33/100 — RISKY
Score breakdown: P/E: 1/3 · ROCE: 0/2 · Growth: 2/2 · Dividend: 0/1
Key Financials
| Current Price | ₹137.85 |
| Market Cap | ₹1,186.06 Cr |
| P/E Ratio | 25.05 |
| ROCE | 0.78% |
| ROE | 24.39% |
| Dividend Yield | 0% |
| Profit Growth | 371.85% |
| Debt/Equity | 0.02 |
| Sales Growth | 17.12% |
| Promoter Holding | 43.06% |
| 52-Week Range | ₹87.15 — ₹173.5 |
| Sector | Pharmaceuticals & Biotechnology |
| Book Value | ₹116.32 |
Ind-Swift Labs. trades with a P/E ratio of 25.05, ROCE of 0.78%, ROE of 24.39%, profit growth of 371.85%, debt-to-equity of 0.02. The FairStock Score of 33/100 flags concerns across multiple fundamental dimensions that investors should examine carefully.
Data from BSE/NSE filings. AI analysis is for educational purposes only — not investment advice. Scoring methodology · Disclaimer